Wave Life Sciences Ltd.
WVE | NASDAQ
$4.37
+$0.12 (+2.70%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -14.05 | -17.67 | -9.35 | -3.41 | -1.33 | -2.06 |
PEG Ratio | -0.19 | -0.60 | 0.13 | 0.26 | 0.03 | 0.07 |
PS Ratio | 67.10 | 15.79 | 4.73 | 151.27 | 3.97 | 15.38 |
PB Ratio | 5.45 | 8.16 | 13.52 | -12.24 | 5.01 | 3.41 |
P/FCF Ratio | -15.29 | -11.26 | -26.08 | -4.27 | -1.82 | -2.63 |
P/OCF Ratio | -15.29 | -11.33 | -27.57 | -4.32 | -1.83 | -2.66 |
OCF/S Ratio | -438.82 | -139.45 | -17.15 | -3.5K | -217.25 | -577.69 |
Debt / Equity Ratio | 0.03 | 0.12 | 0.81 | -0.83 | 0.92 | 0.32 |
Quick Ratio | 6.47 | 2.89 | 1.26 | 1.38 | 2.53 | 1.90 |
Current Ratio | 6.47 | 2.89 | 1.26 | 1.38 | 2.53 | 1.90 |
Asset Turnover | 0.07 | 0.31 | 0.41 | 0.02 | 0.20 | 0.07 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -9.59K |
Return on Equity | -38.84% | -46.30% | -145.12% | 358.88% | -376.16% | -165.37% |
Return on Assets | -32.01% | -27.54% | -20.92% | -110.55% | -59.05% | -53.69% |
Return on Invested Capital | -39.03% | -44.36% | -70.58% | -202.49% | -85.81% | -94.20% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 79.28% | 100% | 100% | 100% | 100% | -552.21% |
Net Profit Margin | -478.33% | -89.57% | -50.76% | -4.43K% | -298.42% | -746.68% |
Pretax Profit Margin | -478.33% | -89.57% | -51.36% | -4.42K% | -298.92% | -750.86% |
Operating Profit Margin | -504.09% | -101.94% | -60.01% | -4.46K% | -310.07% | -763.94% |
FCF Margin | -438.82% | -140.31% | -18.13% | -3.54K% | -218.61% | -584.35% |
EBITDA Margin | -457.62% | -81.57% | -43.23% | -4.14K% | -274.91% | -723.53% |
Add to Watchlist
Select watchlists to add or remove WVE